共 50 条
Cryptic Microheteroresistance Explains Mycobacterium tuberculosis Phenotypic Resistance
被引:30
作者:
Metcalfe, John Z.
[1
]
Streicher, Elizabeth
[2
,3
]
Theron, Grant
[2
,3
]
Colman, Rebecca E.
[4
]
Allender, Christopher
[5
]
Lemmer, Darrin
[5
]
Warren, Rob
[2
,3
]
Engelthaler, David M.
[5
]
机构:
[1] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, 1001 Potrero Ave,Rm 5K1, San Francisco, CA 94110 USA
[2] Stellenbosch Univ, Fac Med & Hlth Sci, DST NRF Ctr Excellence Biomed TB Res, Tygerberg, South Africa
[3] Stellenbosch Univ, Fac Med & Hlth Sci, SAMRC Ctr TB Res, Div Mol Biol & Human Genet, Tygerberg, South Africa
[4] Univ Calif San Diego, Div Pulm Crit Care & Sleep Med, San Diego, CA 92103 USA
[5] Translat Genom Res Inst, Flagstaff, AZ USA
基金:
新加坡国家研究基金会;
英国医学研究理事会;
关键词:
next-generation sequencing;
Sanger sequencing;
drug-resistant tuberculosis;
diagnostics;
DRUG-RESISTANCE;
FLUOROQUINOLONE RESISTANCE;
STREPTOCOCCUS-PNEUMONIAE;
HETERO-RESISTANCE;
GENOMIC ANALYSIS;
SOUTH-AFRICA;
HETERORESISTANCE;
SUSCEPTIBILITY;
MUTATIONS;
DIAGNOSIS;
D O I:
10.1164/rccm.201703-0556OC
中图分类号:
R4 [临床医学];
学科分类号:
1002 ;
100602 ;
摘要:
Rationale: Minority drug-resistant Mycobacterium tuberculosis subpopulations can be associated with phenotypic resistance but are poorly detected by Sanger sequencing or commercial molecular diagnostic assays. Objectives: To determine the role of targeted next-generation sequencing in resolving these minor variant subpopulations. Methods: We used single molecule overlapping reads (SMOR), a targeted next-generation sequencing approach that dramatically reduces sequencing error, to analyze primary cultured isolates phenotypically resistant to rifampin, fluoroquinolones, or aminoglycosides, but for which Sanger sequencing found no resistance-associated variants (RAVs) within respective resistance-determining regions (study group). Isolates also underwent single-colony selection on antibiotic-containing agar, blinded to sequencing results. As a positive control, isolates with multiple colocalizing chromatogram peaks were also analyzed (control group). Measurements and Main Results: Among 61 primary culture isolates (25 study group and 36 control group), SMOR described 66 (49%) and 45 (33%) of 135 total heteroresistant RAVs at frequencies less than 5% and less than 1% of the total mycobacterial population, respectively. In the study group, SMOR detected minor resistant variant subpopulations in 80% (n = 20/25) of isolates with no Sanger-identified RAVs (median subpopulation size, 1.0%; interquartile range, 0.2-3.9%). Single-colony selection on drug-containing media corroborated SMOR results for 90% (n = 18/20) of RAV-containing specimens, and the absence of RAVs in 60% (n = 3/5) of isolates. Overall, Sanger sequencing was concordant with SMOR for 77% (n = 53/69) of macroheteroresistant (5-95% total population), but only 5% of microheteroresistant (< 5%) subpopulations (n = 3/66) across both groups. Conclusions: Cryptic minor variant mycobacterial subpopulations exist below the resolving capability of current drug susceptibility testing methodologies, and may explain an important proportion of false-negative resistance determinations.
引用
收藏
页码:1191 / 1201
页数:11
相关论文
共 50 条